RICI HEALTH (01526) Income Statement & Earnings

0.900
0.0000.00%

Market Closed Apr 17 15:15 CST

1.43BMarket Cap4.21P/E (TTM)

RICI HEALTH (01526) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

-4.41%2.8B

-7.01%1.14B

-2.28%2.92B

-4.14%1.23B

26.01%2.99B

59.64%1.28B

-0.09%2.38B

-19.51%804.54M

23.48%2.38B

71.37%999.53M

Operating income

-4.41%2.8B

-7.01%1.14B

-2.28%2.92B

-4.14%1.23B

26.01%2.99B

59.64%1.28B

-0.09%2.38B

-19.51%804.54M

23.48%2.38B

71.37%999.53M

Cost of sales

9.59%-1.59B

11.70%-737.26M

-0.78%-1.76B

-4.32%-834.92M

-20.40%-1.74B

-24.55%-800.31M

-3.27%-1.45B

11.60%-642.58M

-4.27%-1.4B

-34.29%-726.93M

Operating expenses

9.59%-1.59B

11.70%-737.26M

-0.78%-1.76B

-4.32%-834.92M

-20.40%-1.74B

-24.55%-800.31M

-3.27%-1.45B

11.60%-642.58M

-4.27%-1.4B

-34.29%-726.93M

Gross profit

3.39%1.21B

2.85%407.59M

-6.54%1.17B

-18.13%396.29M

34.76%1.25B

198.87%484.03M

-4.92%927.2M

-40.59%161.96M

67.95%975.22M

549.57%272.61M

Selling expenses

-7.27%-323.8M

-23.81%-134.47M

20.69%-301.85M

33.44%-108.61M

-32.68%-380.58M

-41.13%-163.19M

-13.73%-286.84M

-30.73%-115.63M

-11.44%-252.21M

-25.90%-88.45M

Administrative expenses

16.49%-221.42M

-4.43%-116.74M

-18.45%-265.14M

-11.36%-111.79M

-0.64%-223.85M

-3.12%-100.39M

-1.50%-222.41M

13.52%-97.35M

25.50%-219.14M

17.16%-112.57M

Revaluation surplus

---1.34M

----

-Changes in the fair value of financial assets

---1.34M

----

Impairment and provision

70.81%-10.97M

-235.92%-2.54M

-315.48%-37.57M

178.81%1.87M

-362.24%-9.04M

-203.97%-2.37M

292.09%3.45M

81.86%-781K

-233.96%-1.8M

-232.99%-4.31M

-Other impairment is provision

70.81%-10.97M

-235.92%-2.54M

-315.48%-37.57M

178.81%1.87M

-362.24%-9.04M

-203.97%-2.37M

292.09%3.45M

81.86%-781K

-233.96%-1.8M

-232.99%-4.31M

Special items of operating profit

-65.60%15.24M

90.32%15.12M

112.10%44.29M

-24.03%7.95M

103.05%20.88M

113.75%10.46M

-28.08%10.28M

-47.20%4.89M

0.35%14.3M

35.38%9.27M

Operating profit

9.48%665.08M

-9.01%168.96M

-7.52%607.5M

-18.74%185.7M

52.18%656.92M

587.14%228.54M

-16.40%431.68M

-161.29%-46.91M

581.42%516.38M

149.67%76.55M

Financing income

21.22%5.91M

4.05%3.21M

-53.02%4.87M

-75.28%3.09M

61.57%10.37M

3.93%12.5M

-7.59%6.42M

369.87%12.02M

-17.92%6.95M

-76.33%2.56M

Financing cost

19.63%-103.55M

16.79%-53.3M

-5.08%-128.85M

-4.10%-64.06M

-10.14%-122.62M

-1.79%-61.54M

15.70%-111.33M

27.76%-60.45M

31.88%-132.05M

-1.82%-83.68M

Special items of earning before tax

-122.96%-93K

36.21%568K

-57.72%405K

-5.23%417K

128.64%958K

171.60%440K

-47.82%419K

-11.48%162K

3.61%803K

-6.15%183K

Earning before tax

17.24%567.34M

-4.56%119.44M

-11.31%483.92M

-30.45%125.15M

66.76%545.63M

289.05%179.94M

-16.55%327.19M

-2,068.13%-95.18M

460.29%392.08M

98.05%-4.39M

Tax

-42.58%-184.31M

-4.39%-39.7M

10.02%-129.27M

29.21%-38.03M

-70.94%-143.66M

-359.04%-53.72M

14.57%-84.04M

180.79%20.74M

-702.55%-98.37M

-2.93%-25.67M

After-tax profit from continuing operations

8.00%383.03M

-8.47%79.75M

-11.77%354.66M

-30.98%87.12M

65.32%401.98M

269.55%126.22M

-17.21%243.15M

-147.67%-74.44M

417.53%293.7M

87.99%-30.06M

After-tax profit from non-continuing business

----

114.34%24.04M

---94.11M

---167.6M

----

Special items of earning after tax

----

114.34%24.04M

---94.11M

---167.6M

----

Earning after tax

8.00%383.03M

-8.47%79.75M

-11.77%354.66M

-30.98%87.12M

50.45%401.98M

174.88%126.22M

111.88%267.19M

-460.76%-168.55M

236.33%126.11M

87.99%-30.06M

Minority profit

32.38%75.9M

1,017.56%23.8M

50.20%57.33M

-25.24%2.13M

261.70%38.17M

105.62%2.85M

57.43%-23.61M

-25.13%-50.7M

34.47%-55.45M

52.95%-40.52M

Profit attributable to shareholders

3.30%307.13M

-34.18%55.94M

-18.27%297.32M

-31.11%84.99M

25.11%363.8M

204.68%123.37M

60.17%290.79M

-1,226.71%-117.85M

2,405.14%181.55M

106.37%10.46M

Basic earnings per share

0.00%0.19

-20.00%0.04

-17.39%0.19

-37.50%0.05

27.78%0.23

214.29%0.08

63.64%0.18

-800.00%-0.07

0.11

110.00%0.01

Diluted earnings per share

0.00%0.19

-20.00%0.04

-17.39%0.19

-37.50%0.05

27.78%0.23

214.29%0.08

63.64%0.18

-800.00%-0.07

0.11

110.00%0.01

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Hong Kong Lixin Dehao Certified Public Accountants Limited

PwC

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	-4.41%2.8B	-7.01%1.14B	-2.28%2.92B	-4.14%1.23B	26.01%2.99B	59.64%1.28B	-0.09%2.38B	-19.51%804.54M	23.48%2.38B	71.37%999.53M
Operating income	-4.41%2.8B	-7.01%1.14B	-2.28%2.92B	-4.14%1.23B	26.01%2.99B	59.64%1.28B	-0.09%2.38B	-19.51%804.54M	23.48%2.38B	71.37%999.53M
Cost of sales	9.59%-1.59B	11.70%-737.26M	-0.78%-1.76B	-4.32%-834.92M	-20.40%-1.74B	-24.55%-800.31M	-3.27%-1.45B	11.60%-642.58M	-4.27%-1.4B	-34.29%-726.93M
Operating expenses	9.59%-1.59B	11.70%-737.26M	-0.78%-1.76B	-4.32%-834.92M	-20.40%-1.74B	-24.55%-800.31M	-3.27%-1.45B	11.60%-642.58M	-4.27%-1.4B	-34.29%-726.93M
Gross profit	3.39%1.21B	2.85%407.59M	-6.54%1.17B	-18.13%396.29M	34.76%1.25B	198.87%484.03M	-4.92%927.2M	-40.59%161.96M	67.95%975.22M	549.57%272.61M
Selling expenses	-7.27%-323.8M	-23.81%-134.47M	20.69%-301.85M	33.44%-108.61M	-32.68%-380.58M	-41.13%-163.19M	-13.73%-286.84M	-30.73%-115.63M	-11.44%-252.21M	-25.90%-88.45M
Administrative expenses	16.49%-221.42M	-4.43%-116.74M	-18.45%-265.14M	-11.36%-111.79M	-0.64%-223.85M	-3.12%-100.39M	-1.50%-222.41M	13.52%-97.35M	25.50%-219.14M	17.16%-112.57M
Revaluation surplus	---1.34M	----	----	----	----	----	----	----	----	----
-Changes in the fair value of financial assets	---1.34M	----	----	----	----	----	----	----	----	----
Impairment and provision	70.81%-10.97M	-235.92%-2.54M	-315.48%-37.57M	178.81%1.87M	-362.24%-9.04M	-203.97%-2.37M	292.09%3.45M	81.86%-781K	-233.96%-1.8M	-232.99%-4.31M
-Other impairment is provision	70.81%-10.97M	-235.92%-2.54M	-315.48%-37.57M	178.81%1.87M	-362.24%-9.04M	-203.97%-2.37M	292.09%3.45M	81.86%-781K	-233.96%-1.8M	-232.99%-4.31M
Special items of operating profit	-65.60%15.24M	90.32%15.12M	112.10%44.29M	-24.03%7.95M	103.05%20.88M	113.75%10.46M	-28.08%10.28M	-47.20%4.89M	0.35%14.3M	35.38%9.27M
Operating profit	9.48%665.08M	-9.01%168.96M	-7.52%607.5M	-18.74%185.7M	52.18%656.92M	587.14%228.54M	-16.40%431.68M	-161.29%-46.91M	581.42%516.38M	149.67%76.55M
Financing income	21.22%5.91M	4.05%3.21M	-53.02%4.87M	-75.28%3.09M	61.57%10.37M	3.93%12.5M	-7.59%6.42M	369.87%12.02M	-17.92%6.95M	-76.33%2.56M
Financing cost	19.63%-103.55M	16.79%-53.3M	-5.08%-128.85M	-4.10%-64.06M	-10.14%-122.62M	-1.79%-61.54M	15.70%-111.33M	27.76%-60.45M	31.88%-132.05M	-1.82%-83.68M
Special items of earning before tax	-122.96%-93K	36.21%568K	-57.72%405K	-5.23%417K	128.64%958K	171.60%440K	-47.82%419K	-11.48%162K	3.61%803K	-6.15%183K
Earning before tax	17.24%567.34M	-4.56%119.44M	-11.31%483.92M	-30.45%125.15M	66.76%545.63M	289.05%179.94M	-16.55%327.19M	-2,068.13%-95.18M	460.29%392.08M	98.05%-4.39M
Tax	-42.58%-184.31M	-4.39%-39.7M	10.02%-129.27M	29.21%-38.03M	-70.94%-143.66M	-359.04%-53.72M	14.57%-84.04M	180.79%20.74M	-702.55%-98.37M	-2.93%-25.67M
After-tax profit from continuing operations	8.00%383.03M	-8.47%79.75M	-11.77%354.66M	-30.98%87.12M	65.32%401.98M	269.55%126.22M	-17.21%243.15M	-147.67%-74.44M	417.53%293.7M	87.99%-30.06M
After-tax profit from non-continuing business	----	----	----	----	----	----	114.34%24.04M	---94.11M	---167.6M	----
Special items of earning after tax	----	----	----	----	----	----	114.34%24.04M	---94.11M	---167.6M	----
Earning after tax	8.00%383.03M	-8.47%79.75M	-11.77%354.66M	-30.98%87.12M	50.45%401.98M	174.88%126.22M	111.88%267.19M	-460.76%-168.55M	236.33%126.11M	87.99%-30.06M
Minority profit	32.38%75.9M	1,017.56%23.8M	50.20%57.33M	-25.24%2.13M	261.70%38.17M	105.62%2.85M	57.43%-23.61M	-25.13%-50.7M	34.47%-55.45M	52.95%-40.52M
Profit attributable to shareholders	3.30%307.13M	-34.18%55.94M	-18.27%297.32M	-31.11%84.99M	25.11%363.8M	204.68%123.37M	60.17%290.79M	-1,226.71%-117.85M	2,405.14%181.55M	106.37%10.46M
Basic earnings per share	0.00%0.19	-20.00%0.04	-17.39%0.19	-37.50%0.05	27.78%0.23	214.29%0.08	63.64%0.18	-800.00%-0.07	0.11	110.00%0.01
Diluted earnings per share	0.00%0.19	-20.00%0.04	-17.39%0.19	-37.50%0.05	27.78%0.23	214.29%0.08	63.64%0.18	-800.00%-0.07	0.11	110.00%0.01
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	--	--	Hong Kong Lixin Dehao Certified Public Accountants Limited	--	Hong Kong Lixin Dehao Certified Public Accountants Limited	--	Hong Kong Lixin Dehao Certified Public Accountants Limited	--	PwC	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"